Bharat Biotech develops oral cholera vaccine Hillchol | Indiablooms
Hyderabad: Bharat Biotech International Limited (BBIL) has announced the launch of Hillchol (BBV131), a new single-strain Oral Cholera Vaccine (OCV) developed under a license from Hilleman Laboratories, which is funded by Merck, USA, and…